This study looks at patients aged 60 years or older who are having total hip replacement surgery, which is a procedure to replace a damaged hip joint with an artificial one. The treatment being tested is dexamethasone, a type of medication called a corticosteroid that helps reduce swelling and inflammation in the body. Two different doses of dexamethasone will be used during the surgery: a lower dose of 5 milligrams and a higher dose of 25 milligrams. Both doses will be given as a single injection into a vein during the operation.
The purpose of this study is to find out how different doses of dexamethasone affect quality of life for patients in the three months after hip replacement surgery. Quality of life refers to how well a person feels in their daily activities, including their physical comfort, ability to move around, and overall well-being. The study will compare the effects of the lower dose against the higher dose to see which one works better for helping patients recover and feel better after their surgery.
During the study, patients will receive one of the two doses of dexamethasone during their hip replacement operation. After the surgery, patients will be asked to complete questionnaires at different time points to measure how they are feeling and recovering. These questionnaires will ask about their quality of life, recovery progress, hip function, pain levels, and tiredness at various times following the surgery, including on days 1, 3, and 5, as well as at 30, 60, and 90 days after the operation. The study will help doctors understand which dose of dexamethasone might be more helpful for patients recovering from hip replacement surgery.



Belgium